Viramune®

nevirapine

About Viramune®

For the combination therapy of HIV-1 infection and (in several countries) for the prevention of mother-to-child transmission of HIV-1 in pregnant women who are not taking antiretroviral therapy at time of labour.
Prolonged release tablets for once-daily dosing within combination therapy.

 

Professional Area

You are a Healthcare Professional or Journalists & Media Professional? Click below to be able to see and access respective content.

Product Key Facts

Indications

HIV/AIDS

Brand Names

Viramune® Viramune XR®

Active ingredients

nevirapine